Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

INSM stock hub

Insmed Incorporated has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INSMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

22B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INSM

In the news

Latest news · INSM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-294.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-42.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INSM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001104506
Company name	Insmed Incorporated
Country	United States
Country code	US
Cusip	457669307
Employees	1,664
Employees Change	393%
Employees Change Percent	30.92
Enterprise value	$21.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
In Index	NASDAQ100
Industry	Biotechnology
IPO Date	2000-06-01
Isin	US4576693075
Last refreshed	2026-05-10
Market cap	$22B
Market cap category	Large-Cap
Price	$101
Price currency	USD
Rev Per Employee	492,526.44x
Sector	Healthcare
Sic	2834
Symbol	INSM
Website	https://www.insmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.39%
EV Sales Forward	10.91x
EV/Sales	26.22x
FCF yield	-4.2%
P/B ratio	31.13x
P/S ratio	26.8x
PS Forward	11.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-117.77%
EBITDA Margin	-115.8%
Gross margin	81.81%
Gross Profit	$670.5M
Gross Profit Growth	130.04%
Gross Profit Growth Q	261.37%
Gross Profit Growth3 Y	49.49%
Gross Profit Growth5 Y	36.55%
Net Income	$-1.2B
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-143.76%
Profit Margin	-144.44%
Profit Per Employee	$-711,391
ROA	-31.11
Roa5y	-25.98
ROCE	-56.29
ROE	-294.5
ROIC	-42.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	24.75%
Cagr15y	18.26%
Cagr1y	48.47%
Cagr20y	8.96%
Cagr3y	73.5%
Cagr5y	25.48%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	115.09x
Revenue Growth Q	229.62x
Revenue Growth Quarters	21x
Revenue Growth Years	7x
Revenue Growth3 Y	47.1x
Revenue Growth5 Y	37.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$2.1B
Cash	$1.2B
Current Assets	$1.6B
Current Liabilities	$361M
Debt	$742.5M
Debt Equity	$1.05
Equity	$704.9M
Interest Coverage	-11.73
Liabilities	$1.4B
Long Term Assets	$462.7M
Long Term Liabilities	$1B
Net Cash	$481.1M
Net Cash By Market Cap	$2.19
Net Debt Equity	$-0.68
Tangible Book Value	$495M
Tangible Book Value Per Share	$2.29
WACC	9.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.47
Inventory Turnover	1.28
Net Working Capital	$37.1M
Quick ratio	3.88
Working Capital	$1.3B
Working Capital Turnover	$0.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.64%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	812.24%
1Y total return	48.43%
200-day SMA	155.8
3Y total return	422.42%
50-day SMA	144.1
50-day SMA vs 200-day SMA	50under200
5Y total return	211.08%
All Time High	212.8
All Time High Change	-52.36%
All Time High Date	2025-12-02
All Time Low	2.64
All Time Low Change	3,739.02%
All Time Low Date	2011-11-25
ATR	7.66
Beta	0.89
Beta1y	-0.09
Beta2y	0.5
Ch YTD	-41.77
High	108.6
High52	212.8
High52 Date	2025-12-02
High52ch	-52.36%
Low	98.98
Low52	63.81
Low52 Date	2025-05-08
Low52ch	58.83%
Ma50ch	-29.69%
Premarket Change Percent	3.43
Premarket Price	$109
Premarket Volume	21,507
Price vs 200-day SMA	-34.96%
RSI	21.32
RSI Monthly	48.08
RSI Weekly	30.58
Sharpe ratio	0.91x
Sortino ratio	1.51
Total Return	-20.64%
Tr YTD	-41.77
Tr15y	1,137.49%
Tr1m	-37.83%
Tr1w	-23.95%
Tr3m	-32.37%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	24
Analyst Count Top	12
Analyst Price Target Top	$203
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.98
Earnings Revenue Estimate	302,256,848x
Earnings Revenue Estimate Growth	225.63x
Operating Income	$-965.2M
Operating margin	-117.8
Price target	$200
Price Target Change	$97.5
Price Target Change Top	$101

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	194,394,629%
Float Percent	89.69%
Net Borrowing	-5,019,000
Shares Insiders	0.62%
Shares Institutions	91.58%
Shares Out	216,752,451
Shares Qo Q	0.86%
Shares Yo Y	20.64%
Short Float	7.13%
Short Ratio	5.41
Short Shares	6.39

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-1.1B
Average Volume	2,627,645.35x
Bv Per Share	3.26
CAPEX	$-26M
Ch10y	812.2
Ch15y	1,137.5
Ch1m	-37.83
Ch1w	-23.95
Ch1y	48.43
Ch20y	456.3
Ch3m	-32.37
Ch3y	422.4
Ch5y	211.1
Ch6m	-46.57
Change	-3.48%
Change From Open	-6.17
Close	105
Days Gap	2.87
Depreciation Amortization	16,181,000
Dollar Volume	870,391,671.7
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-965.2M
EBITDA	$-949M
EPS	$-5.7
F Score	4
FCF	$-921.6M
FCF EV Yield	-4.29x
FCF Per Share	$-4.25
Financing CF	954,589,000
Fiscal Year End	December
Founded	1,988
Goodwill	136,110,000
Income Tax	$5.6M
Investing CF	120,533,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2011-03-03
Last Split Type	Reverse
Last10k Filing Date	2026-02-19
Ma150	164.2
Ma150ch	-38.28%
Ma20	137.2
Ma20ch	-26.14%
Net CF	178,941,000
Next Earnings Date	2026-08-06
Open	108
Optionable	Yes
Position In Range	24.56
Post Close	101.4
Postmarket Change Percent	1.63
Postmarket Price	$103
Ppne	204,233,000
Pre Close	105
Price Date	2026-05-08
Ptbv Ratio	44.38
Relative Volume	3.27x
Revenue	819,564,000x
SBC By Revenue	19.43x
Share Based Comp	159,202,000
Tax By Revenue	0.68x
Tr20y	456.26%
Tr6m	-46.57%
Us State	New Jersey
Volume	8,587,979
Z Score	7.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INSM pay a dividend?

Capital-return profile for this ticker.

Performance

INSM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INSM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+91.6%

Float: +89.7% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INSM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

21.3

Below 30: short-term oversold

Price vs 200-day MA

-35.0%

50/200-day relationship not available

Beta (5Y)

0.89

Moves roughly with the market

Sharpe ratio

0.91

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INSM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INSM stock rating?

Insmed Incorporated is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INSM analysis?

The full report lives at /stocks/INSM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INSM?

The latest report frames INSM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INSM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.